Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830933 · ClinicalTrials.gov registry record · NA
Breast Cancer Risk Reduction: A Patient Doctor Intervention
A NA study of Breast Cancer, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,235
- Enrollment target
- 2
- Study locations
NCT01830933: Completed NA study of Breast Cancer, sponsored by University of California, San Francisco.
NCT01830933 is a NA study of Breast Cancer that has completed, run by University of California, San Francisco. The registered enrollment target is 1,235 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01830933, a NA study of Breast Cancer, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,235 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.
Primary Outcome
Risk knowledge was assessed using a post-survey. Participants could have scored 0-100 (with 0 meaning no correct answers, and 100 is all correct answers). This outcome was measured through a survey. Breast cancer risk knowledge was based on a series of eight questions in the survey. O
Conditions Studied
Interventions
- OTHER BreastCARE
Study Locations (2)
California
- San Francisco General Hospital (SFGH) - San Francisco
- University of California, San Francisco Mt. Zion campus - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,235 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01830933 record still lists
NCT01830933 is an interventional study that assigns participants to a tested intervention. Its 1,235 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which BreastCARE is the first listed.
NCT01830933 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01830933 about?
NCT01830933 is a clinical study titled "Breast Cancer Risk Reduction: A Patient Doctor Intervention". The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer ris...
What is the current status of trial NCT01830933?
This trial is currently completed. It is a NA study. The enrollment target is 1,235 participants. The study started on 2011-06. Estimated completion is 2012-12.
What conditions does trial NCT01830933 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01830933?
The interventions under investigation include: BreastCARE (OTHER).
Who is sponsoring clinical trial NCT01830933?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01830933 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01830933's enrollment target sits among peer trials
1,235 102nd of 1224 higher than 1,123 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05456841 · 1,232 participants · NA
Empathic Communication Skills (ECS) Training
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia